These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cronkhite-Canada syndrome: report of two cases, biopsy findings in the associated alopecia, and a new treatment option. Allbritton J; Simmons-O'Brien E; Hutcheons D; Whitmore SE Cutis; 1998 Apr; 61(4):229-32. PubMed ID: 9564598 [TBL] [Abstract][Full Text] [Related]
5. The challenging diagnosis of Cronkhite-Canada syndrome in the upper gastrointestinal tract: a series of 7 cases with clinical follow-up. Bettington M; Brown IS; Kumarasinghe MP; de Boer B; Bettington A; Rosty C Am J Surg Pathol; 2014 Feb; 38(2):215-23. PubMed ID: 24418855 [TBL] [Abstract][Full Text] [Related]
6. Cronkhite-Canada syndrome: report of a rare case and review of the literature. Liu Y; Zhang L; Yang Y; Peng T J Int Med Res; 2020 May; 48(5):300060520922427. PubMed ID: 32459145 [TBL] [Abstract][Full Text] [Related]
8. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans. Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334 [TBL] [Abstract][Full Text] [Related]
9. Telogen elongation in the hair cycle of ob/ob mice. Tasaki N; Minematsu T; Mugita Y; Ikeda S; Nakagami G; Sanada H Biosci Biotechnol Biochem; 2016; 80(1):74-9. PubMed ID: 26239026 [TBL] [Abstract][Full Text] [Related]
11. Cronkhite-Canada syndrome with hypothyroidism. Qiao M; Lei Z; Nai-Zhong H; Jian-Ming X South Med J; 2005 May; 98(5):575-6. PubMed ID: 15954520 [TBL] [Abstract][Full Text] [Related]
12. A severe course of Cronkhite-Canada syndrome and the review of clinical features and therapy in 49 Chinese patients. She Q; Jiang JX; Si XM; Tian XY; Shi RH; Zhang GX Turk J Gastroenterol; 2013; 24(3):277-85. PubMed ID: 24226722 [TBL] [Abstract][Full Text] [Related]
15. [A patient with chronic diarrhoe, head pigmentation and alopecia. Cronkhite-Canada syndrome]. Fischer R; Breidert M; Paul S; Kreisel W; Schmitt-Gräff A; Waller C; Blum HE Dtsch Med Wochenschr; 2010 Feb; 135(8):339-42. PubMed ID: 20165997 [TBL] [Abstract][Full Text] [Related]
16. Telogen effluvium. Harrison S; Sinclair R Clin Exp Dermatol; 2002 Jul; 27(5):389-5. PubMed ID: 12190639 [TBL] [Abstract][Full Text] [Related]
17. Cases Report the Cronkhite-Canada Syndrome: Improving the Prognosis. Yu YQ; Whorwell PJ; Wang LH; Li JX; Chang Q; Meng J Medicine (Baltimore); 2015 Dec; 94(52):e2356. PubMed ID: 26717374 [TBL] [Abstract][Full Text] [Related]
18. Kenogen in female androgenetic alopecia. A longitudinal study. Guarrera M; Rebora A Dermatology; 2005; 210(1):18-20. PubMed ID: 15604539 [TBL] [Abstract][Full Text] [Related]
19. Follicular density and ratios in scarring and nonscarring alopecia. Horenstein MG; Bacheler CJ Am J Dermatopathol; 2013 Dec; 35(8):818-26. PubMed ID: 23435361 [TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 is expressed on multipotent cells of hair follicles and might be involved in their resistance to chemotherapy. Selleri S; Arnaboldi F; Palazzo M; Hussein U; Balsari A; Rumio C Br J Dermatol; 2005 Sep; 153(3):506-13. PubMed ID: 16120134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]